0001385849-25-000044
SEC filingUranium sales drove 338% revenue growth to $17.7M but gross margin fell to 27.8% from 54.4% due to higher-cost inventory.
For the three months ended September 30, 2025, Energy Fuels reported total revenue of $17.71 million, a 338% increase from $4.05 million in the same period of 2024. The surge was entirely driven by the uranium segment, which sold 240,000 pounds of U3O8 (up 380% from 50,000 lbs) at a realized price of $72.38/lb (down 10% from $80.00/lb). Costs applicable to revenues rose to $12.78 million, resulting in a gross profit of $4.93 million (27.8% margin) compared to $2.20 million (54.4% margin) in the prior year. The margin compression reflects higher-cost inventory from blending lower-grade ores and Alternate Feed Materials.
Operating expenses ballooned to $44.38 million from $15.96 million, driven by higher exploration, development and processing costs (including a $3.42 million VAT write-off), increased SG&A from Base Resources headcount, and a $2.27 million rise in share-based compensation. The operating loss widened to $26.67 million from $11.91 million. Other income of $8.27 million (mainly mark-to-market gains on marketable securities) and a $1.81 million gain on asset sales partially offset the loss, resulting in a net loss of $17.01 million (vs. $12.08 million). Basic and diluted EPS remained at $(0.07).
Uranium: Revenues of $17.37 million accounted for 98% of total revenue. Volume growth was the primary driver (240k lbs vs. 50k lbs), but realized price fell 10% and cost per pound rose 44% to $53.22, reflecting the weighted average cost of finished inventories that included higher-cost sources. The Company commenced processing high-grade Pinyon Plain ore in Q4 2025, which is expected to lower costs to $23-$30/lb in subsequent quarters.
Rare Earth Elements: No revenue was generated in Q3 2025. The Phase 1 separation circuit produced 38 tonnes of NdPr and pilot quantities of Dy. On September 9, 2025, the Company announced that its NdPr oxide was successfully manufactured into commercial-scale permanent magnets for EV drive units, qualifying it for use by major automotive OEMs. The Company expects minimal profit until throughput rates increase (2027-2028).
Heavy Mineral Sands: No revenue in Q3 2025. The Kwale mine ceased production in December 2024; remaining inventories were sold in Q1/Q2 2025 at a loss due to lower-grade ore. The Company does not expect further HMS sales until new projects (Donald, Toliara) come online.
Management’s revised 2025 guidance targets uranium mined of 875k-1,435k lbs, processed of 700k-1,000k lbs, and sales of 350k lbs (excluding potential spot sales). The Company expects to produce 1.1-1.4 million lbs of finished U3O8 during the Q4 2025-Q1 2026 mill run, with a cost of goods sold of approximately $23-$30/lb from Pinyon Plain ore, declining from the current ~$53/lb. This should expand gross margins significantly.
Strategic priorities include advancing the Donald Project (targeting FID by Q1 2026), the Toliara Project (FID as early as 2026), and the Phase 2 REE expansion at White Mesa Mill (expected 2028). The $700 million convertible note offering (closed October 3, 2025) provides liquidity for these initiatives. The Company also has an active ATM program ($300M remaining) for equity financing.
Key risks include political instability in Madagascar, permitting delays, and uranium price volatility. The Company’s ability to blend various uranium feedstocks and its growing inventory position (485k lbs finished and 1,640k lbs in ore) provide operational flexibility to meet long-term contracts and capitalize on spot market opportunities.
As of September 30, 2025, the Company held $93.96M in cash and cash equivalents and $149.53M in marketable securities (current and non-current), totaling $243.49M in liquid assets. Total assets were $758.32M, up from $611.97M at December 31, 2024, driven largely by a $236.58M increase in share capital from ATM offerings and the Base Resources acquisition. Total liabilities decreased to $50.75M from $80.29M, primarily due to a $19.95M settlement of asset retirement obligations. Shareholders' equity rose to $703.25M from $527.79M. The Company had no outstanding debt as of September 30, 2025, but subsequent to quarter-end, on October 3, 2025, it issued $700.0M aggregate principal of 0.75% Convertible Senior Notes due 2031, significantly altering the capital structure.
Asset retirement obligations totaled $26.79M as of September 30, 2025, down from $44.12M at year-end 2024, reflecting $19.95M in settlements. The Company has $22.66M posted as collateral against undiscounted AROs of $55.68M. Under non-cancelable uranium sales contracts, the Company expects to recognize $4.00M for the remainder of 2025, $93.36M over the next three years, and $26.40M thereafter. Mineral property lease renewal costs for the remainder of 2025 are expected to total approximately $0.54M. The Company also has a contingent consideration liability of $1.75M related to the RadTran acquisition.
No share buybacks or dividends were declared or paid during the nine months ended September 30, 2025. The Company raised $226.84M net from ATM offerings during the period. Capital expenditures totaled $32.84M, comprising $9.80M for property, plant and equipment and $23.04M for mineral properties. Subsequent to quarter-end, the Company issued $700.0M in convertible notes and paid $53.55M for capped call transactions to reduce potential dilution. The Company also invested $9.34M in other investments and $189.58M in marketable securities (with $127.91M in maturities).
The Company reports three segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). For the nine months ended September 30, 2025, Uranium generated $23.0M in revenue (down from $38.2M YoY) and an operating loss of $29.0M. REE had no revenue and an operating loss of $13.3M. HMS generated $15.8M in revenue (all from HMS sales) and an operating loss of $36.7M. The HMS segment includes costs from the Kwale, Bahia, and Toliara projects, as well as equity method losses from the Donald Project JV and Tate. Corporate unallocated expenses (transaction and integration costs) were $4.75M in the prior year period but $0 in the current period.